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Abstract 
BACKGROUND: Stem cells have recently received great interest as potential therapeutics alternative for a 
variety of diseases. The oral and maxillofacial region, in particular, encompasses a variety of distinctive 
mesenchymal (MSC) populations and is characterized by a potent multilineage differentiation capacity. 
AIM: In this report, we aimed to investigate the effect of diabetes on the proliferation potential of stem cells 
isolated from controlled diabetic patients (type 2) and healthy individuals.  
SUBJECTS & METHODS: The proliferation rate of gingival and periodontal derived stem cells isolated from 
diabetic & healthy individuals were compared using MTT Assay. Expression levels of Survivin in isolated stem 
cells from all groups were measured by qRt - PCR. 
RESULTS: There was a significantly positive correlation between proliferation rate and expression of Survivin in 
all groups which sheds light on the importance of Survivin as a reliable indicator of proliferation. The expression of 
Survivin further confirmed the proliferation results from MTT Assay where the expression of stem cells from non - 
diabetic individuals was higher than diabetic patients. Conclusion: Taking together all the results, it could be 
concluded that PDLSC and GSC are promising candidates for autologous regenerative therapy due to their ease 
of accessibility in addition to their high proliferative rates. 
 
 
Introduction 
 
The capacity of mesenchymal stem cells to 
self - renew and to differentiate into multiple cells 
strongly suggests their role as a promising candidate 
for future cell-based therapies [1][2][3]. The oral and 
maxillofacial region encompasses a variety of 
distinctive mesenchymal (MSC) populations, isolated 
from the tooth and its supporting structures, and is 
characterised by a potent multilineage differentiation 
capacity and immunomodulatory properties 
[1][2][3][4][5]. Of those are the gingival mesenchymal 
stem cells (GMSCs) which offer a more appealing 
alternative to other dental originated MSCs regarding 
their ease of extraction and isolation from the clinically 
respected gingival tissues with minimal harm to the 
donor. GMSCs are considered an excellent source of 
MSCs for cell-based regenerative therapies with 
maximum stability for the longest period in addition to 
its uniformly homogenous property and stable 
phenotype and telomerase activity during prolonged 
culture time [3][6][7][8]. Periodontal ligament stem 
cells (PDLSCs) also represent typical properties of 
mesenchymal stem cells (MSCs) regarding self - 
renewal and expression of mesenchymal stem cells 
surface markers. PDLSCs also possess multilineage 
differentiation potential into various types of cells such 
as osteoblasts, adipocytes, chondrocytes and 
neurocytes in - vitro. Additionally, it is suggested that 
PDLSCs might belong to a unique population of 
somatic stem cells due to its distinctive potential to 
form cementum and PDL - like tissues in - vivo. 9 It is 
believed that PDLSCs are a suitable candidate 
cellular source for PDL regeneration as they play an 
endogenous role in maintaining PDL cell numbers due 
to their periodontal ligament derivation and their vast 
differentiation capacity [10]. In the current study, 
GMSCs and PDLSCs were recruited since both are 
currently considered ideal cell source for tissue 
engineering and repair [11]. Previous studies 
confirmed that GMSCs transplanted into the 
periodontal defects had been demonstrated to 
contribute to the periodontal repair and regeneration 
[12]. Novel studies had demonstrated the great 
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potential of bone healing when GMSCs were 
implemented into the mandibular defects in animal 
models [13]. In recent years, several research groups 
have attempted to use MSCs as a treatment option for 
diabetes and its complications [1][2][3][4][5][6][7][8]. 
However, autologous cell-based therapeutics may be 
unlikely to succeed if the true impact of diseases like 
diabetes on stem cells and progenitor cell population 
is not investigated thoroughly. It is thought that 
diabetes negatively affects the stem cell niches thus 
altering their dynamics and disrupting the repair and 
homeostasis. Predominantly, changes in reactive 
oxygen species (ROS) and hypoxia from neighbouring 
cells in case of hyperglycemia (high blood glucose 
level) is the reason for the alteration of the signalling 
to the stem cells [14][15]. Diabetes produces a surge 
in ROS which results in generating a prolonged 
inflammatory and oxidative environment that leads to 
the inhibition of stem cell proliferation which in turn 
causes stem cell senescence impairing innate tissue 
repair mechanisms and regeneration [16][17].  
Diabetes also causes stem cell aberrations 
resulting in direct implications on tissue function that 
seem to persist even after return to normoglycemia 
[18]. These impairments might include changes in 
migration, recruitment, survival, self - renewal and 
differentiation capacity. Diabetes-induced in mice was 
found to alter the intrinsic properties of stem cells and 
impair their function and their regenerative ability 
[19][20]. Stem cells investigated in these reports were 
isolated from tissues other than dental tissues like 
adipose and bone marrow and has provided 
accumulating evidence that implies differences in 
proliferation and differentiation abilities between 
different sources of stem cells [18][20][21][22][23]. 
However, most of these reports have either 
investigated stem cells from healthy individuals 
without comparing the results to diabetic individuals or 
has used diabetic induced models.  
In this report, we investigate the effect of 
diabetes on the proliferation potential of stem cells 
isolated from controlled diabetic patients (type II) and 
healthy individuals. 
 
 
Subjects and Methods 
 
Periodontal ligament stem cells were isolated 
from (PDLSCs) of healthy subjects and controlled 
diabetic patients (DM type II). Additionally, gingival 
mesenchymal stem cells (GMSCs) were isolated from 
the gingiva of healthy subjects and controlled diabetic 
patients (DM type II). Procedures were performed at 
the National Research Centre, Cairo, Egypt according 
to the recommendations and approval of its ethics 
committee. Informed consent was obtained from all 
subjects and patients before undergoing teeth 
extractions. 
Sample Size Calculation 
Based on previous studies, the expected 
average of cell viability was 26.2% with variance 
percentage 1.86% [24][25]. A total sample size of 116 
(29 in each of the four groups) was calculated to be 
sufficient to detect a significant difference between the 
groups with a power of 80% and a significant level of 
5%. The number was then increased to a total sample 
size of 144 (36 in each group) to allow for losses of 
around 25%. The sample size was calculated using 
nQuery Advisor. 
 
Inclusion and Exclusion Criteria 
The sample represents a population of 
Egyptian patients with type 2 diabetes of both sexes, 
≥ 18 years of age. Participants represent a 
consecutive series of patients fulfilling the 
exclusion/inclusion criteria. Patients were recruited 
among those referred to the hospital of the faculty of 
dentistry and oral medicine, Cairo University for dental 
treatment. Inclusion Criteria included; clinical 
diagnosis of diabetes mellitus according to American 
Diabetes Association criteria (ADA) criteria [26], 
whose age ranged from 18 to 69 years, with duration 
of diabetes diagnosis over 12 months, and requiring 
oral antidiabetic drugs for optimal glycemic control in a 
dose of ≥ 0.7 U/kg/day at least for 1 year in addition to 
willingness to participate in the study. 
Control diabetes was described as proven 
normal glucose tolerance according to ADA criteria 
where uncontrolled diabetes was deemed present in 
diabetics who had fasting blood glucose (FBG) level ≥ 
7.0 mmol/L and controlled diabetes in diabetics who 
had fasting blood glucose (FBG) level ≤ 7.0 mmol/L 
[26][27]. At the time of entry into the study, all patients 
had a fasting blood glucose (FBG) level ≤ 7.0 mmol/L 
and HbA1c ≤ 7%. The exclusion criteria included the 
following: acute or chronic infections; any 
malignancies; haematological diseases; known 
immunosuppressive disease (for example, acquired 
immunodeficiency); acute or chronic pancreatitis; and 
a history of thoracic or abdominal aorta diseases. 
After recruitment, all follow - up visits were performed 
at the same hospital. All patients gave written 
informed consent. 
 
Cell Isolation and Culture 
Human third molars, which were removed for 
impact reason from both systemically healthy and 
diabetic patients, were used for tissue biopsy and PDL 
cell isolation. Meanwhile, gingival tissues surrounding 
the tooth sockets were collected immediately after 
tooth extraction for gingival cell isolation and 
subsequent investigations. Periodontal ligament stem 
cells (PDLSCs) were acquired from the periodontal 
ligament tissues by scraping the middle third of the 
root of extracted impacted third molars. Teeth 
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surfaces were rinsed with phosphate buffered saline 
(PBS) under aseptic conditions. The collected tissues 
were then digested with 3 mg/ml collagenase at 37°C 
for 15 min. The cell suspension was then transferred 
to dishes and cultured in RPMI culture media 
supplemented with 10% Fetal Bovine Serum (FBS) 
and streptomycin at 37°C in a humidified atmosphere 
with 5% CO2. The culture medium was changed every 
three days. 
In parallel, a small of biopsy of gingiva 
comprised of epithelium and connective tissues was 
harvested from the extracted third molar’s cervical 
ridge, and the tissue was washed with PBS. The 
excised gingival tissues were and treated aseptically 
and incubated overnight at 4°C with 2 mg/ml Dispase 
to separate the epithelial and the spinous layers. The 
tissues were then minced into fragments and digested 
with 4 mg/ml collagenase at 37°C for two h. The 
dissociated cell suspension were filtered through a 70 
μm cell strainer, plated on Petri dishes RPMI culture 
media supplemented with 10% Fetal Bovine Serum 
(FBS) and streptomycin at 37°C in a humidified 
atmosphere with CO2. The culture medium was 
changed every three days. Cells from all groups were 
passaged at a ratio of 1:2 when reaching 70 - 80% 
confluence. The collected stem cells were grouped as 
follows; periodontal ligament stem cells from healthy 
individuals, periodontal ligament from controlled 
diabetic patients, gingival stem cells from healthy 
individuals and gingival stem cells from controlled 
diabetic patients. 
 
Flow Cytometric Analysis 
The identity of isolated stem cells was 
confirmed by analysing surface antigen expression. 
Isolated stem cells from all groups at passage three 
were detached by 0.05 % trypsin - EDTA, centrifuged 
for 5 min at 2000 rpm and resuspended in PBS 
containing 2 % FBS. Next, they were incubated with 
antibodies against CD45, CD90 and CD105 for 30 min 
at 4°C. Isotypes were used as negative control. After 
washing with PBS, the cells were resuspended in 500 
μl PBS containing 2 % FBS and subjected to flow 
cytometric analyses using CYTOMICS FC 500 Flow 
Cytometer (Beckman Coulter, FL, USA) and analysed 
using CXP Software version 2.2. 
 
Assessment of Cell Proliferation by MTT 
Assay 
The proliferation of isolated stem cells was 
evaluated using MTT assay. For MTT assay, the cells 
from passage three were seeded in 96 - well plates (2 
x 103 cells per well) and cultured for 72h in DMEM 
supplemented with antibiotic and 10% FBS. Then, 
MTT solution (at the final concentration of 0.05 %) 
was added to each well, and the cells were incubated 
under the atmosphere of 5 % CO2 at 37°C. After 3h, 
the supernatant was discarded, and the formazan 
precipitate was dissolved in dimethyl sulfoxide. The 
MTT Reagent and Detergent Solution were obtained 
from TACSTM TREVIGEN1 8405 Hegerman Ct. 
Gaithersburg, supplied ready for use. The optical 
density (O.D) values were measured at a range from 
490 to 630 nm using an ELISA reader (Dynatech MRX 
5000; Dynex, Chantilly, VA). 
 
Real-time Quantitative PCR for Survivin 
Gene Expression 
Total RNA of cells of all studied groups was 
isolated with RNAeasy Mini Kit (Qiagen) and further 
analysed for quantity and quality with Beckman dual 
spectrophotometer (USA). The mRNA expression 
level was quantified by qRT - PCR (Real-time PCR). 
1000 mg of the total RNA from each sample was used 
for cDNA synthesis by reverse transcription using 
High Capacity cDNA Reverse Transcriptase kit 
(Applied Biosystem, USA). The cDNA was 
subsequently amplified with the Syber Green I PCR 
Master Kit (Fermentas) in a 48 - well plate using the 
Step One instrument (Applied Biosystem, USA) as 
follows: 10 min at 95°C for enzyme activation followed 
by 40 cycles of 15 seconds at 95°C, 20 seconds at 
55°C and 30 second at 72°C for the amplification step. 
Changes in the expression of each target gene were 
normalized relative to the mean critical threshold (CT) 
values of beta actin housekeeping gene by the ∆∆Ct 
method. We used 1 mM of both primers specific for 
each target gene. Survivin primer sequence was 5' - 
ACCCACACTGTGCCCATCTAC - 3' and antisense 5' 
– TCGGTGAGGATCTTCATGAGGTA - 3' (gene bank 
accession number: NG_026370.2) and β - beta actin 
primer sequence was 5' - GGC 
GGCACCACCATGTACCCT - 3' and antisense 5' - 
AGG GGCCGGACTCGTCATACT - 3' (gene bank 
accession number: NM_001101.3). 
 
Statistical Analysis 
Data were coded and entered using the 
statistical package SPSS (Statistical Package for the 
Social Sciences) version 23. Data was summarized 
using median and interquartile range in quantitative 
data. Comparisons between quantitative variables 
were done using the non - parametric Kruskal - Wallis 
and Mann - Whitney tests. Correlations between 
quantitative variables were done using Spearman 
correlation coefficient. P - values less than 0.05 were 
considered as statistically significant. 
 
Results 
MSCs morphology 
MSCs were identified in culture by adopting a 
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fusiform adherent fibroblast like cells in both types 
PDLSCs and GMSCs for healthy subjects and 
diabetic patients (Figure 1). 
Flow Cytometric Analysis 
Surface antigens of all groups were analysed 
by ﬂow cytometry. GSCs & PDLSCs isolated from 
healthy & diabetic patients demonstrated relatively 
high positivity for mesenchymal stem cell-associated 
markers CD 90 and CD 105, and negative for 
hematopoietic markers CD45 (Figure1). 
 
Figure 1: MSCs isolated from all groups in culture; A: PDLSCs isolated from 
healthy subjects, B: GMSCs isolated from healthy subjects, C: PDLSCs 
isolated from diabetic patients and D: GMSCs isolated from diabetic patients 
(Left).FACS analysis for characterisation of isolated MSCs; A: PDLSCs 
isolated from healthy subjects, B: GMSCs isolated from healthy subjects, C: 
PDLSCs isolated from diabetic patients and D: GMSCs isolated from diabetic 
patients. Analysis for all groups revealed high positivity of CD 90 and 105 and 
negativity of CD 45 for all types of isolated MSCs (Right) 
 
Cell Proliferation by MTT Assay 
Figure 2 illustrates the proliferation of 
PDLSCs and GSCs from normal & diabetic patients 
as evaluated by MTT assay.  
 
Figure 2: Proliferation of periodontal ligament stem cells (PDLS) and gingival 
stem cells (GSCs) from normal and diabetic individuals by MTT assay (* 
indicates statistically significant differences between normal and diabetic 
individuals in each cell type P < 0.001) 
 
Both in normal and diabetic individuals 
PDLSCs exhibited greater proliferation rate than 
GSCs nearly two-fold higher. When comparing 
proliferation of each cell type about diabetes, it was 
revealed that the proliferation rate of PDLSC derived 
from normal individuals was significantly higher than 
those derived from diabetic individuals. The same 
pattern was noticed in GSCs where the proliferation 
rate was significantly higher in normal cells. The 
increase in normal PDLSCs was seven folds higher 
than that in diabetics and 5.29 folds higher in case of 
GSCs (P < 0.001). 
 
Real-time Quantitative PCR 
The expression of Survivin in PDLSCs & 
GSCs from normal and diabetic patients by Rt - PCR 
is illustrated in Table 1. Statistical analysis revealed 
that Survivin expression in PDLSCs isolated from 
normal individuals was significantly higher than those 
from diabetic patients (P < 0.05). Similarly, GSCs 
isolated from normal individuals exhibited expression 
that is significantly higher than GSCsc from diabetic 
individuals (P < 0.001). 
Table 1: Survivin expression when comparing PDLSCs normal 
group with diabetic group, and GSCs normal group with 
diabetic group using multiple comparison post hoc tests (* P - 
value when comparing PDLSCs group versus PDLSCs diabetic 
group, ** P - value when comparing GSCs group versus GSCs 
diabetic group) 
 MSCs PDLs 
Normal 
MSCs PDLs 
Diabetic 
MSCs 
Normal 
Gingival 
MSCs 
Normal 
Diabetic 
P - value 
Survivin Gene 
Expression 
1.24* 0.54 0.84** 0.26 
< 0.001 
SD 0.74 0.15 0.32 0.07 
 
 
Assessment of the relation between 
proliferation rate and Survivin Gene 
expression  
Next, we analysed the correlation between 
Proliferation rate & Survivin Gene Expression. There 
was a significantly positive correlation between 
proliferation rate and expression of Survivin in all 
groups illustrating the importance of Survivin as a 
reliable indicator of proliferation (Figure 3 and Table 
2). 
 
Figure 3: A plot of Survivin gene expression in all groups by RT - PCR (Left) 
and the relation of its expression with the proliferation potential of studied 
stem cells groups 
 
Table 2: Correlation between Proliferation and Survivin 
expression 
 Proliferation 
 
 
 
Survivin Gene Expression 
 .621 
Correlation Coefficient 
P value  <0.001  
 
N 56 
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Discussion 
  
Stem cells have recently received great 
interest as a potential therapeutic alternative for a 
variety of diseases. This is especially true for a 
disease like diabetes. The majority of mesenchymal 
stem cells previously studied for therapeutic purposes 
have been from sources like bone marrow and 
adipose tissue [23][28]. Both, PDLSCs and GSCs 
demonstrated promising potential for use in tissue 
regeneration [29][30][31]. In the present study, we 
investigated stem cells isolated from two different oral 
tissues. Moreover, to address whether oral stem cells 
derived from different oral tissues have different 
proliferation ability and whether controlled type II 
diabetes influences these abilities, we compared the 
growth rate of gingival and periodontal derived stem 
cells isolated from diabetic & healthy individuals. 
Our results showed that both PDLMSCs and 
GMSCs demonstrate satisfactory proliferation rates. 
We observed a significant difference in the 
proliferation pattern of both tissues. Stem cells 
isolated from PDL exhibited higher proliferation than 
those isolated from gingival tissues both in normal and 
diabetic patients. This was in contrast to multiple 
reports that showed GMSCs to have a higher 
proliferation compared to PDLSCs [29][32][33][34]. 
This pattern of proliferation described in the diabetic 
patient was in contrast to previous reports that 
demonstrated that early after the induction of diabetes 
with streptozotocin, the proliferative capacity of bone 
marrow-derived stem cells increased [23]. The 
inclusion of a greater number of diabetics enrolled in 
our study in contrast to using diabetes-induced 
models may help explain this result. Our results were 
in consistence with Stolzing et al who attributed the 
diminished proliferative capacity of bone marrow cells 
to the long-term incidence of diabetes [35]. 
It is worthy to note that in the present study 
both PDLMSCs and GMSCs were phenotypically 
similar in diabetic and non - diabetic groups as 
demonstrated by FACS analysis. The homogeneity of 
the results in all groups suggests that diabetes has 
not altered the stemness of either population 
confirming that the changes associated with diabetes 
mainly affect the proliferation capacity of the cells. 
To further assess the effect of diabetes on 
PDLSCs and GSCs, we measured the expression 
levels of Survivin in isolated stem cells from all groups 
and correlated its expression with the proliferation 
patterns studied. Survivin is a critical inhibitor of 
apoptosis-inducing proteins that are up-regulated in 
many types of malignant diseases. Additionally, it has 
been demonstrated previously that Survivin 
expression is correlated with the expression of cell 
proliferation and survival markers [36]. In the present 
study, there was a significantly positive correlation 
between proliferation rate and expression of Survivin 
in all groups which sheds light on the importance of 
Survivin as a reliable indicator of proliferation. The 
expression on Survivin further confirmed the 
proliferation results from MTT Assay where the 
expression of stem cells from non - diabetic 
individuals was higher than diabetic patients and PDL 
stem cells demonstrated significantly higher 
expression than GSCs. Taking together all the results, 
it could be concluded that PDLSC and GSC are 
promising candidates for autologous regenerative 
therapy due to their ease of accessibility in addition to 
their high proliferative rates. However, it could also be 
concluded that stem cells from diabetic donors exhibit 
decreased proliferative potential while maintaining 
their stemness properties. Thus it is essential to 
improve methods and factors that would increase the 
proliferation capacity of stem cells isolated from 
diabetic patients to ensure the success of 
regenerative medicine options especially when 
autologous cells are intended for use. 
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